ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Tablet and Capsule Budesonide Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-38H10034
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Tablet and Capsule Budesonide Market Insights Forecast to 2028
BUY CHAPTERS

Global Tablet and Capsule Budesonide Market Research Report 2025

Code: QYRE-Auto-38H10034
Report
July 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
TEVA
Mylan NV
Sandoz Inc
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla Ltd
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod

Tablet and Capsule Budesonide Market Size

The global market for Tablet and Capsule Budesonide was valued at US$ 1037 million in the year 2024 and is projected to reach a revised size of US$ 1764 million by 2031, growing at a CAGR of 8.0% during the forecast period.

Tablet and Capsule Budesonide Market

Tablet and Capsule Budesonide Market

Tablets or capsules made of budesonide micropowder.
North American market for Tablet and Capsule Budesonide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Tablet and Capsule Budesonide is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Tablet and Capsule Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Tablet and Capsule Budesonide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tablet and Capsule Budesonide.
The Tablet and Capsule Budesonide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Tablet and Capsule Budesonide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Tablet and Capsule Budesonide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Tablet and Capsule Budesonide Market Report

Report Metric Details
Report Name Tablet and Capsule Budesonide Market
Accounted market size in year US$ 1037 million
Forecasted market size in 2031 US$ 1764 million
CAGR 8.0%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tablet
  • Capsule
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Tablet and Capsule Budesonide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Tablet and Capsule Budesonide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Tablet and Capsule Budesonide Market growing?

Ans: The Tablet and Capsule Budesonide Market witnessing a CAGR of 8.0% during the forecast period 2025-2031.

What is the Tablet and Capsule Budesonide Market size in 2031?

Ans: The Tablet and Capsule Budesonide Market size in 2031 will be US$ 1764 million.

Who are the main players in the Tablet and Capsule Budesonide Market report?

Ans: The main players in the Tablet and Capsule Budesonide Market are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod

What are the Application segmentation covered in the Tablet and Capsule Budesonide Market report?

Ans: The Applications covered in the Tablet and Capsule Budesonide Market report are Respiratory Disease Treatment, Nose Disease Treatment, Inflammatory Bowel Disease Treatment, Other

What are the Type segmentation covered in the Tablet and Capsule Budesonide Market report?

Ans: The Types covered in the Tablet and Capsule Budesonide Market report are Tablet, Capsule

Recommended Reports

Respiratory Therapeutics

Tablet & Capsule Technology

Capsule Drug Markets

1 Tablet and Capsule Budesonide Market Overview
1.1 Product Definition
1.2 Tablet and Capsule Budesonide by Type
1.2.1 Global Tablet and Capsule Budesonide Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.3 Tablet and Capsule Budesonide by Application
1.3.1 Global Tablet and Capsule Budesonide Market Value by Application (2024 VS 2031)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.3.5 Other
1.4 Global Tablet and Capsule Budesonide Market Size Estimates and Forecasts
1.4.1 Global Tablet and Capsule Budesonide Revenue 2020-2031
1.4.2 Global Tablet and Capsule Budesonide Sales 2020-2031
1.4.3 Global Tablet and Capsule Budesonide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Tablet and Capsule Budesonide Market Competition by Manufacturers
2.1 Global Tablet and Capsule Budesonide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Tablet and Capsule Budesonide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Tablet and Capsule Budesonide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Tablet and Capsule Budesonide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Tablet and Capsule Budesonide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Tablet and Capsule Budesonide, Product Type & Application
2.7 Global Key Manufacturers of Tablet and Capsule Budesonide, Date of Enter into This Industry
2.8 Global Tablet and Capsule Budesonide Market Competitive Situation and Trends
2.8.1 Global Tablet and Capsule Budesonide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Tablet and Capsule Budesonide Players Market Share by Revenue
2.8.3 Global Tablet and Capsule Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Tablet and Capsule Budesonide Market Scenario by Region
3.1 Global Tablet and Capsule Budesonide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Tablet and Capsule Budesonide Sales by Region: 2020-2031
3.2.1 Global Tablet and Capsule Budesonide Sales by Region: 2020-2025
3.2.2 Global Tablet and Capsule Budesonide Sales by Region: 2026-2031
3.3 Global Tablet and Capsule Budesonide Revenue by Region: 2020-2031
3.3.1 Global Tablet and Capsule Budesonide Revenue by Region: 2020-2025
3.3.2 Global Tablet and Capsule Budesonide Revenue by Region: 2026-2031
3.4 North America Tablet and Capsule Budesonide Market Facts & Figures by Country
3.4.1 North America Tablet and Capsule Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Tablet and Capsule Budesonide Sales by Country (2020-2031)
3.4.3 North America Tablet and Capsule Budesonide Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Tablet and Capsule Budesonide Market Facts & Figures by Country
3.5.1 Europe Tablet and Capsule Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Tablet and Capsule Budesonide Sales by Country (2020-2031)
3.5.3 Europe Tablet and Capsule Budesonide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Tablet and Capsule Budesonide Market Facts & Figures by Region
3.6.1 Asia Pacific Tablet and Capsule Budesonide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Tablet and Capsule Budesonide Sales by Region (2020-2031)
3.6.3 Asia Pacific Tablet and Capsule Budesonide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Tablet and Capsule Budesonide Market Facts & Figures by Country
3.7.1 Latin America Tablet and Capsule Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Tablet and Capsule Budesonide Sales by Country (2020-2031)
3.7.3 Latin America Tablet and Capsule Budesonide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Tablet and Capsule Budesonide Market Facts & Figures by Country
3.8.1 Middle East and Africa Tablet and Capsule Budesonide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Tablet and Capsule Budesonide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Tablet and Capsule Budesonide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Tablet and Capsule Budesonide Sales by Type (2020-2031)
4.1.1 Global Tablet and Capsule Budesonide Sales by Type (2020-2025)
4.1.2 Global Tablet and Capsule Budesonide Sales by Type (2026-2031)
4.1.3 Global Tablet and Capsule Budesonide Sales Market Share by Type (2020-2031)
4.2 Global Tablet and Capsule Budesonide Revenue by Type (2020-2031)
4.2.1 Global Tablet and Capsule Budesonide Revenue by Type (2020-2025)
4.2.2 Global Tablet and Capsule Budesonide Revenue by Type (2026-2031)
4.2.3 Global Tablet and Capsule Budesonide Revenue Market Share by Type (2020-2031)
4.3 Global Tablet and Capsule Budesonide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Tablet and Capsule Budesonide Sales by Application (2020-2031)
5.1.1 Global Tablet and Capsule Budesonide Sales by Application (2020-2025)
5.1.2 Global Tablet and Capsule Budesonide Sales by Application (2026-2031)
5.1.3 Global Tablet and Capsule Budesonide Sales Market Share by Application (2020-2031)
5.2 Global Tablet and Capsule Budesonide Revenue by Application (2020-2031)
5.2.1 Global Tablet and Capsule Budesonide Revenue by Application (2020-2025)
5.2.2 Global Tablet and Capsule Budesonide Revenue by Application (2026-2031)
5.2.3 Global Tablet and Capsule Budesonide Revenue Market Share by Application (2020-2031)
5.3 Global Tablet and Capsule Budesonide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AstraZeneca
6.1.1 AstraZeneca Company Information
6.1.2 AstraZeneca Description and Business Overview
6.1.3 AstraZeneca Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AstraZeneca Tablet and Capsule Budesonide Product Portfolio
6.1.5 AstraZeneca Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Tablet and Capsule Budesonide Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Mylan
6.3.1 Mylan Company Information
6.3.2 Mylan Description and Business Overview
6.3.3 Mylan Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Mylan Tablet and Capsule Budesonide Product Portfolio
6.3.5 Mylan Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sandoz Tablet and Capsule Budesonide Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Cosmo Pharmaceuticals
6.5.1 Cosmo Pharmaceuticals Company Information
6.5.2 Cosmo Pharmaceuticals Description and Business Overview
6.5.3 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Cosmo Pharmaceuticals Tablet and Capsule Budesonide Product Portfolio
6.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
6.6 Salix
6.6.1 Salix Company Information
6.6.2 Salix Description and Business Overview
6.6.3 Salix Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Salix Tablet and Capsule Budesonide Product Portfolio
6.6.5 Salix Recent Developments/Updates
6.7 Chiesi Farmaceutici
6.7.1 Chiesi Farmaceutici Company Information
6.7.2 Chiesi Farmaceutici Description and Business Overview
6.7.3 Chiesi Farmaceutici Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Chiesi Farmaceutici Tablet and Capsule Budesonide Product Portfolio
6.7.5 Chiesi Farmaceutici Recent Developments/Updates
6.8 Orion Corporation
6.8.1 Orion Corporation Company Information
6.8.2 Orion Corporation Description and Business Overview
6.8.3 Orion Corporation Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Orion Corporation Tablet and Capsule Budesonide Product Portfolio
6.8.5 Orion Corporation Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cipla Tablet and Capsule Budesonide Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Synmosa Biopharma
6.10.1 Synmosa Biopharma Company Information
6.10.2 Synmosa Biopharma Description and Business Overview
6.10.3 Synmosa Biopharma Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Synmosa Biopharma Tablet and Capsule Budesonide Product Portfolio
6.10.5 Synmosa Biopharma Recent Developments/Updates
6.11 Lunan Better Pharma
6.11.1 Lunan Better Pharma Company Information
6.11.2 Lunan Better Pharma Description and Business Overview
6.11.3 Lunan Better Pharma Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lunan Better Pharma Tablet and Capsule Budesonide Product Portfolio
6.11.5 Lunan Better Pharma Recent Developments/Updates
6.12 Shanghai Sine Promod
6.12.1 Shanghai Sine Promod Company Information
6.12.2 Shanghai Sine Promod Description and Business Overview
6.12.3 Shanghai Sine Promod Tablet and Capsule Budesonide Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Sine Promod Tablet and Capsule Budesonide Product Portfolio
6.12.5 Shanghai Sine Promod Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Tablet and Capsule Budesonide Industry Chain Analysis
7.2 Tablet and Capsule Budesonide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Tablet and Capsule Budesonide Production Mode & Process Analysis
7.4 Tablet and Capsule Budesonide Sales and Marketing
7.4.1 Tablet and Capsule Budesonide Sales Channels
7.4.2 Tablet and Capsule Budesonide Distributors
7.5 Tablet and Capsule Budesonide Customer Analysis
8 Tablet and Capsule Budesonide Market Dynamics
8.1 Tablet and Capsule Budesonide Industry Trends
8.2 Tablet and Capsule Budesonide Market Drivers
8.3 Tablet and Capsule Budesonide Market Challenges
8.4 Tablet and Capsule Budesonide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
TEVA
Mylan NV
Sandoz Inc
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla Ltd
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod
List of Tables
 Table 1. Global Tablet and Capsule Budesonide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Tablet and Capsule Budesonide Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Tablet and Capsule Budesonide Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Tablet and Capsule Budesonide Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Tablet and Capsule Budesonide Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Tablet and Capsule Budesonide Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Tablet and Capsule Budesonide Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Tablet and Capsule Budesonide Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Tablet and Capsule Budesonide, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Tablet and Capsule Budesonide, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Tablet and Capsule Budesonide, Product Type & Application
 Table 12. Global Key Manufacturers of Tablet and Capsule Budesonide, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Tablet and Capsule Budesonide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tablet and Capsule Budesonide as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Tablet and Capsule Budesonide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Tablet and Capsule Budesonide Sales by Region (2020-2025) & (K Units)
 Table 18. Global Tablet and Capsule Budesonide Sales Market Share by Region (2020-2025)
 Table 19. Global Tablet and Capsule Budesonide Sales by Region (2026-2031) & (K Units)
 Table 20. Global Tablet and Capsule Budesonide Sales Market Share by Region (2026-2031)
 Table 21. Global Tablet and Capsule Budesonide Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Tablet and Capsule Budesonide Revenue Market Share by Region (2020-2025)
 Table 23. Global Tablet and Capsule Budesonide Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Tablet and Capsule Budesonide Revenue Market Share by Region (2026-2031)
 Table 25. North America Tablet and Capsule Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Tablet and Capsule Budesonide Sales by Country (2020-2025) & (K Units)
 Table 27. North America Tablet and Capsule Budesonide Sales by Country (2026-2031) & (K Units)
 Table 28. North America Tablet and Capsule Budesonide Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Tablet and Capsule Budesonide Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Tablet and Capsule Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Tablet and Capsule Budesonide Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Tablet and Capsule Budesonide Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Tablet and Capsule Budesonide Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Tablet and Capsule Budesonide Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Tablet and Capsule Budesonide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Tablet and Capsule Budesonide Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Tablet and Capsule Budesonide Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Tablet and Capsule Budesonide Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Tablet and Capsule Budesonide Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Tablet and Capsule Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Tablet and Capsule Budesonide Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Tablet and Capsule Budesonide Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Tablet and Capsule Budesonide Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Tablet and Capsule Budesonide Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Tablet and Capsule Budesonide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Tablet and Capsule Budesonide Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Tablet and Capsule Budesonide Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Tablet and Capsule Budesonide Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Tablet and Capsule Budesonide Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Tablet and Capsule Budesonide Sales (K Units) by Type (2020-2025)
 Table 51. Global Tablet and Capsule Budesonide Sales (K Units) by Type (2026-2031)
 Table 52. Global Tablet and Capsule Budesonide Sales Market Share by Type (2020-2025)
 Table 53. Global Tablet and Capsule Budesonide Sales Market Share by Type (2026-2031)
 Table 54. Global Tablet and Capsule Budesonide Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Tablet and Capsule Budesonide Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Tablet and Capsule Budesonide Revenue Market Share by Type (2020-2025)
 Table 57. Global Tablet and Capsule Budesonide Revenue Market Share by Type (2026-2031)
 Table 58. Global Tablet and Capsule Budesonide Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Tablet and Capsule Budesonide Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Tablet and Capsule Budesonide Sales (K Units) by Application (2020-2025)
 Table 61. Global Tablet and Capsule Budesonide Sales (K Units) by Application (2026-2031)
 Table 62. Global Tablet and Capsule Budesonide Sales Market Share by Application (2020-2025)
 Table 63. Global Tablet and Capsule Budesonide Sales Market Share by Application (2026-2031)
 Table 64. Global Tablet and Capsule Budesonide Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Tablet and Capsule Budesonide Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Tablet and Capsule Budesonide Revenue Market Share by Application (2020-2025)
 Table 67. Global Tablet and Capsule Budesonide Revenue Market Share by Application (2026-2031)
 Table 68. Global Tablet and Capsule Budesonide Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Tablet and Capsule Budesonide Price (US$/Unit) by Application (2026-2031)
 Table 70. AstraZeneca Company Information
 Table 71. AstraZeneca Description and Business Overview
 Table 72. AstraZeneca Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AstraZeneca Tablet and Capsule Budesonide Product
 Table 74. AstraZeneca Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Tablet and Capsule Budesonide Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Mylan Company Information
 Table 81. Mylan Description and Business Overview
 Table 82. Mylan Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Mylan Tablet and Capsule Budesonide Product
 Table 84. Mylan Recent Developments/Updates
 Table 85. Sandoz Company Information
 Table 86. Sandoz Description and Business Overview
 Table 87. Sandoz Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Sandoz Tablet and Capsule Budesonide Product
 Table 89. Sandoz Recent Developments/Updates
 Table 90. Cosmo Pharmaceuticals Company Information
 Table 91. Cosmo Pharmaceuticals Description and Business Overview
 Table 92. Cosmo Pharmaceuticals Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Cosmo Pharmaceuticals Tablet and Capsule Budesonide Product
 Table 94. Cosmo Pharmaceuticals Recent Developments/Updates
 Table 95. Salix Company Information
 Table 96. Salix Description and Business Overview
 Table 97. Salix Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Salix Tablet and Capsule Budesonide Product
 Table 99. Salix Recent Developments/Updates
 Table 100. Chiesi Farmaceutici Company Information
 Table 101. Chiesi Farmaceutici Description and Business Overview
 Table 102. Chiesi Farmaceutici Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Chiesi Farmaceutici Tablet and Capsule Budesonide Product
 Table 104. Chiesi Farmaceutici Recent Developments/Updates
 Table 105. Orion Corporation Company Information
 Table 106. Orion Corporation Description and Business Overview
 Table 107. Orion Corporation Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Orion Corporation Tablet and Capsule Budesonide Product
 Table 109. Orion Corporation Recent Developments/Updates
 Table 110. Cipla Company Information
 Table 111. Cipla Description and Business Overview
 Table 112. Cipla Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Cipla Tablet and Capsule Budesonide Product
 Table 114. Cipla Recent Developments/Updates
 Table 115. Synmosa Biopharma Company Information
 Table 116. Synmosa Biopharma Description and Business Overview
 Table 117. Synmosa Biopharma Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Synmosa Biopharma Tablet and Capsule Budesonide Product
 Table 119. Synmosa Biopharma Recent Developments/Updates
 Table 120. Lunan Better Pharma Company Information
 Table 121. Lunan Better Pharma Description and Business Overview
 Table 122. Lunan Better Pharma Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Lunan Better Pharma Tablet and Capsule Budesonide Product
 Table 124. Lunan Better Pharma Recent Developments/Updates
 Table 125. Shanghai Sine Promod Company Information
 Table 126. Shanghai Sine Promod Description and Business Overview
 Table 127. Shanghai Sine Promod Tablet and Capsule Budesonide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Shanghai Sine Promod Tablet and Capsule Budesonide Product
 Table 129. Shanghai Sine Promod Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Tablet and Capsule Budesonide Distributors List
 Table 133. Tablet and Capsule Budesonide Customers List
 Table 134. Tablet and Capsule Budesonide Market Trends
 Table 135. Tablet and Capsule Budesonide Market Drivers
 Table 136. Tablet and Capsule Budesonide Market Challenges
 Table 137. Tablet and Capsule Budesonide Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Tablet and Capsule Budesonide
 Figure 2. Global Tablet and Capsule Budesonide Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Tablet and Capsule Budesonide Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Global Tablet and Capsule Budesonide Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Tablet and Capsule Budesonide Market Share by Application: 2024 & 2031
 Figure 8. Respiratory Disease Treatment
 Figure 9. Nose Disease Treatment
 Figure 10. Inflammatory Bowel Disease Treatment
 Figure 11. Other
 Figure 12. Global Tablet and Capsule Budesonide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Tablet and Capsule Budesonide Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Tablet and Capsule Budesonide Sales (2020-2031) & (K Units)
 Figure 15. Global Tablet and Capsule Budesonide Average Price (US$/Unit) & (2020-2031)
 Figure 16. Tablet and Capsule Budesonide Report Years Considered
 Figure 17. Tablet and Capsule Budesonide Sales Share by Manufacturers in 2024
 Figure 18. Global Tablet and Capsule Budesonide Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Tablet and Capsule Budesonide Players: Market Share by Revenue in Tablet and Capsule Budesonide in 2024
 Figure 20. Tablet and Capsule Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Tablet and Capsule Budesonide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Tablet and Capsule Budesonide Sales Market Share by Country (2020-2031)
 Figure 23. North America Tablet and Capsule Budesonide Revenue Market Share by Country (2020-2031)
 Figure 24. United States Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Tablet and Capsule Budesonide Sales Market Share by Country (2020-2031)
 Figure 27. Europe Tablet and Capsule Budesonide Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Tablet and Capsule Budesonide Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Tablet and Capsule Budesonide Revenue Market Share by Region (2020-2031)
 Figure 35. China Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Tablet and Capsule Budesonide Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Tablet and Capsule Budesonide Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Tablet and Capsule Budesonide Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Tablet and Capsule Budesonide Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Tablet and Capsule Budesonide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Tablet and Capsule Budesonide by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Tablet and Capsule Budesonide by Type (2020-2031)
 Figure 56. Global Tablet and Capsule Budesonide Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Tablet and Capsule Budesonide by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Tablet and Capsule Budesonide by Application (2020-2031)
 Figure 59. Global Tablet and Capsule Budesonide Price (US$/Unit) by Application (2020-2031)
 Figure 60. Tablet and Capsule Budesonide Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Budesonide Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Inhalation Powder Budesonide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Budesonide Market Research Report 2025
Budesonide Aerosol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Aerosols Budesonide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Budesonide Inhaler Market Research Report 2024
Budesonide API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Budesonide Commercial Medicine Market Research Report 2025
Pulmicort Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Asthma and COPD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Liquid Formulation Capsule Market Research Report 2025
Global Budesonide and Formoterol Powder Inhalation Market Research Report 2024
Global Pharmaceutical Excipients for Oral Formulations Market Research Report 2024
Solid Microspheres Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tablets and Capsules Packaging Market Research Report 2024
Global Corticosteroid Injections for Joint Pain Market Insights Forecast to 2030
COPD Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Steroid Corticosteroids Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Budesonide and Formoterol Inhalation Market Research Report 2024
Intranasal Drug and Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions